NEW YORK (GenomeWeb News) – A bill to create a national institute to study comparative clinical effectiveness of medical treatments and diagnostics — including the use of molecular medicine and genetics to inform those studies — was introduced in the US Senate this week by Senators Max Baucus (D – Mont.) and Kent Conrad (D – ND).

The bill calls for the creation of the Patient-Centered Outcomes Research Institute, which would be a non-profit entity run by "a multi-stakeholder, public-private sector board of governors," Baucus said in a floor statement to the Senate on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.